GABAergic Involvement in Selective Attention

Area of Science:

• Neuroscience
• Cognitive Psychology

Background:

• Selective attention is crucial for managing sensory input.
• The role of gamma-aminobutyric acid (GABA) in selective attention is not fully understood.
• Benzodiazepines like lorazepam increase GABAA receptor activity and can slow cognitive task performance.

Purpose of the Study:

• To investigate whether increased GABAA receptor activity slows attentional selectivity or broadens attentional focus.
• To clarify the specific role of GABAergic neurotransmission in selective attention mechanisms.

Main Methods:

• A double-blind, within-subjects study using lorazepam and placebo in 29 participants performing an extended flanker task.
• Systematic manipulation of flanker number and position to assess spatial distribution of attention.
• Delta plot analysis of reaction times (RTs) to characterize temporal build-up of selectivity.
• Verification of task effects using an independent, unmedicated online sample (n=25).

Main Results:

• Under placebo and in the unmedicated group, only the number, not position, of incongruent flankers affected RTs.
• Lorazepam significantly impaired RTs compared to placebo, particularly with adjacent flankers.
• Delta plot analysis indicated that lorazepam's effect was not due to slowed selectivity build-up, but persisted even with slower reactions.

Conclusions:

• Increased GABAA receptor activity, induced by lorazepam, appears to widen attentional focus.
• This widening of attentional focus, rather than a general slowing of processing, explains lorazepam's impact on selective attention performance.